Genelux GNLX
NASDAQ GNLX
$2.01 -0.06 (-2.90%)
As of: Oct 22, 2026 · 10:16 AM EDT

Genelux (GNLX) Long-Term Debt Issuances (2023)

Updated

Genelux's Long-Term Debt Issuances was $900,000 in FY2023, down 18.2% from $1.1 million in FY2022.

Analysis

Genelux (GNLX) Long-Term Debt Issuances (2023) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $1.1 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,164.71 Bn 1,133.30 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 633.37 Bn 551.90 Bn 17.26 Bn -
3 AbbVie 503.99 Bn 477.10 Bn 12.70 Bn -
4 Merck 378.19 Bn 332.57 Bn 12.21 Bn -
5 Novartis Ag 303.15 Bn 267.14 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 266.17 Bn 239.85 Bn 12.86 Bn -
7 Amgen 241.38 Bn 196.78 Bn 7.24 Bn -
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn -
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn -
10 Genelux 89.18 Mn 27.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 900,000.00
API Access

Genelux Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=GNLX&period=max&api_key=YOUR_API_KEY